Question

Difficulty: HardPharmacologic Interventions

A 76-year-old woman is admitted to the hospital from the emergency department due to a 3-day history of a productive cough, fever, and worsening shortness of breath. Her past medical history is significant for hypertension, type 2 diabetes mellitus, and major depressive disorder. Her current medications include lisinopril, metformin, and citalopram. She has a documented allergy to amoxicillin, which caused a maculopapular rash on her trunk when she was a teenager; she has never experienced anaphylaxis, wheezing, or lip swelling.

Vital signs include a temperature of 38.7∘C38.7^\circ\text{C} (101.7∘F101.7^\circ\text{F}), blood pressure of 118/74 mmHg118/74\text{ mmHg}, pulse of 102/min102/\text{min}, and respiratory rate of 26/min26/\text{min}. Pulse oximetry shows 91%91\% on room air. Physical examination reveals bronchial breath sounds and crackles in the right lower lung field. Laboratory studies show a leukocyte count of 14,500/μL14,500/\mu\text{L} with 85%85\% neutrophils. Chest radiograph demonstrates a right lower lobe consolidation. An electrocardiogram obtained on admission shows normal sinus rhythm with a QTc interval of 495 ms495\text{ ms}.

Which of the following is the most appropriate empiric pharmacologic intervention for this patient?

  1. A
    Aztreonam and doxycycline
  2. B
    Ceftriaxone and azithromycin
  3. Ceftriaxone and doxycyclineAnswer
  4. D
    Levofloxacin
  5. E
    Piperacillin-tazobactam and vancomycin

Answer

The most appropriate regimen is ceftriaxone and doxycycline. This provides necessary typical and atypical microbial coverage while avoiding QTc prolongation in a patient with a high baseline QTc and concurrent citalopram use.
The correct regimen perfectly balances empiric coverage for inpatient community-acquired pneumonia (CAP) with vital safety constraints. Inpatient CAP requires coverage for both typical (Streptococcus pneumoniae, Haemophilus influenzae) and atypical (Mycoplasma, Legionella) pathogens. Standard regimens include a beta-lactam plus a macrolide, or a respiratory fluoroquinolone. However, this patient's QTc interval is significantly prolonged at 495 ms, and she is taking citalopram, an SSRI known to independently prolong the QTc. Administering azithromycin or levofloxacin would unacceptably increase her risk of Torsades de pointes. Doxycycline provides excellent atypical coverage without affecting ventricular repolarization. Furthermore, her childhood history of a maculopapular rash to amoxicillin does not preclude the use of ceftriaxone, as cross-reactivity is less than 1% and the original reaction was not IgE-mediated (anaphylactic).

Step-by-Step Solution

1
Diagnose the clinical condition and determine the required treatment setting.
The patient has community-acquired pneumonia (CAP) requiring inpatient admission (based on age, vital signs, and oxygen saturation).
Establishing the severity and setting dictates the empiric antibiotic guidelines (e.g., inpatient ward requires beta-lactam plus a macrolide, or a respiratory fluoroquinolone).
2
Evaluate the patient's allergy history to select a safe primary agent for typical pathogens.
The patient has a history of a childhood maculopapular rash to amoxicillin. A third-generation cephalosporin like ceftriaxone is safe.
A maculopapular rash is not an IgE-mediated anaphylactic reaction. The cross-reactivity between penicillins and third-generation cephalosporins is extremely low, making ceftriaxone the standard of care over unnecessarily avoiding all beta-lactams.
3
Assess the patient's medication list and ECG findings for potential contraindications to standard atypical coverage options.
The patient is taking citalopram and has a baseline QTc interval of 495 ms. Macrolides (azithromycin) and fluoroquinolones (levofloxacin) must be avoided.
Citalopram is known to cause dose-dependent QTc prolongation. Using a macrolide or fluoroquinolone in a patient with an already prolonged QTc (>460 ms in women) significantly increases the risk of life-threatening Torsades de pointes.
4
Select the optimal regimen that fulfills both microbiologic requirements and patient safety constraints.
Doxycycline is chosen for atypical coverage because it does not prolong the QTc interval.
Combining ceftriaxone and doxycycline perfectly addresses the infectious etiology of CAP while navigating the patient's low-risk penicillin allergy and high-risk cardiac electrical profile.

Key Concept

Pharmacologic selection in community-acquired pneumonia must integrate antimicrobial spectrum guidelines with patient-specific safety profiles, particularly avoiding QTc-prolonging antibiotics (macrolides, fluoroquinolones) in high-risk patients and appropriately utilizing cephalosporins in non-anaphylactic penicillin allergies.
Rate this question